Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study

SIMPLE SUMMARY: In this study, based on the results of chemotherapy or poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) maintenance in other tumors, we explore whether olaparib, a PARP inhibitor, could be useful in terms of prolonging radiographic progression of the disease in patients with meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Juan Fita, María José, Anido Herranz, Urbano, Mendez-Vidal, María José, Gironés-Sarrió, Regina, Muñoz-Langa, José, Sepúlveda-Sánchez, Juan, Mellado, Begoña, Alvarez-Fernandez, Carlos, Heras López, Lucía, López-Guerrero, José Antonio, García-Casado, Zaida, Calatrava, Ana, Ángel Climent, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649956/
https://www.ncbi.nlm.nih.gov/pubmed/37958398
http://dx.doi.org/10.3390/cancers15215223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649956/
https://www.ncbi.nlm.nih.gov/pubmed/37958398
http://dx.doi.org/10.3390/cancers15215223

Ejemplares similares